Speaker illustration

Doctor Yeshen Zhang

Changsha (China)

PhD candidate in Xiangya School of Medicine, Central South University; Fellow-in-training of the American College of Cardiology; He focuses on basic and clinical research on coronary heart disease and has published SCI as first/co-first author in Am J Obstet Gynecol, Cardiovasc Diabetol, Eur J Prev Cardiol, etc; He currently serves as a reviewer for Lipids in Health and Disease, International Journal of Endocrinology, and Cardiovascular Innovations and Applications.

The prognostic value of advanced lung cancer inflammation index in cancer survivors complicated with cardiovascular disease

Event: ESC Congress 2024

Topic: Cardio-Oncology

Session: Challenges when caring for cancer patients with heart disease

Thumbnail

Association of neutrophil-percentage-to-albumin ratio with mortality in cardiovascular disease patients complicating abnormal glucose metabolism

Event: ESC Congress 2024

Topic: Biomarkers

Session: Cancer and other risk factors for heart disease

Thumbnail